SCHEMBL21145733

SCHEMBL21145733

Cc1ccccc1C(=O)N/N=C/c1cccc(O)c1O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 2/20 0.65
MEN1 O00255 4/20 0.63
KMT2A Q03164 4/20 0.63
KDM4E B2RXH2 3/20 0.63
CYP3A4 P08684 2/20 0.63
CYP2D6 P10635 2/20 0.63
MAPK1 P28482 2/20 0.63
TP53 P04637 1/20 0.63
HPGD P15428 1/20 0.63
HSD17B10 Q99714 1/20 0.63
TDP1 Q9NUW8 1/20 0.63
NOX4 Q9NPH5 1/20 0.62
RAB9A P51151 4/20 0.61
NPC1 O15118 3/20 0.61
SMN1; SMN2 Q16637 3/20 0.61
RRM1 P23921 1/20 0.60
KDM1A O60341 1/20 0.59
MGAM O43451 2/20 0.58
GAA P10253 2/20 0.58
SI P14410 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21145734 1.00 NTRK1 (0.65) NTRK1MEN1KMT2AKDM4ECYP3A4
SCHEMBL1639836 0.89 MEN1 (0.72) NTRK1MEN1KMT2AKDM4ECYP3A4
SCHEMBL12767340 0.89 MEN1 (0.72) NTRK1MEN1KMT2AKDM4ECYP3A4
SCHEMBL1639834 0.89 MEN1 (0.72) NTRK1MEN1KMT2AKDM4ECYP3A4
SCHEMBL29695425 0.89 NTRK1 (0.81) NTRK1MEN1KMT2AKDM4ECYP3A4
SCHEMBL1639422 0.89 NTRK1 (0.81) NTRK1MEN1KMT2AKDM4ECYP3A4
SCHEMBL1639424 0.89 NTRK1 (0.81) NTRK1MEN1KMT2AKDM4ECYP3A4
SCHEMBL10049700 0.89 NTRK1 (0.81) NTRK1MEN1KMT2AKDM4ECYP3A4
SCHEMBL13952237 0.87 NOX4 (0.71) NTRK1MEN1KMT2AKDM4ECYP3A4
SCHEMBL21145742 0.85 KDM4E (0.70) MEN1KMT2AKDM4EMAPK1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3515427-A2 N-METHYL-D-ASPARTATE RECEPTOR ALLOSTERIC MODULATORS AND METHODS FOR THEIR USE Qingdao Primedicine Pharmaceutical Co., Ltd (CN) 2019-07-31 EP claimed
US-11166924-B2 N-methyl-d-aspartate receptor allosteric modulators and methods for their use QINGDAO PRIMEDICINE PHARMACEUTICAL COMPANY, LTD. (CN) 2021-11-09 US disclosed
US-11166924-B2 N-methyl-d-aspartate receptor allosteric modulators and methods for their use QINGDAO PRIMEDICINE PHARMACEUTICAL COMPANY, LTD. (CN) 2021-11-09 US disclosed
US-20190216753-A1 N-METHYL-D-ASPARTATE RECEPTOR ALLOSTERIC MODULATORS AND METHODS FOR THEIR USE QINGDAO PRIMEDICINE PHARMACEUTICAL COMPANY, LTD. (CN) 2019-07-18 US disclosed
US-20190216753-A1 N-METHYL-D-ASPARTATE RECEPTOR ALLOSTERIC MODULATORS AND METHODS FOR THEIR USE QINGDAO PRIMEDICINE PHARMACEUTICAL COMPANY, LTD. (CN) 2019-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190216753-A1 N-METHYL-D-ASPARTATE RECEPTOR ALLOSTERIC MODULATORS AND METHODS FOR THEIR USE GRIN2A, GRIN3A, GRIN1 NTRK1 560/4885MEN1 4774/4885KMT2A 585/4885
US-11166924-B2 N-methyl-d-aspartate receptor allosteric modulators and methods for their use GRIN2A, GRIN3A, GRIN1 NTRK1 560/4885MEN1 4774/4885KMT2A 585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.